Human amniotic fluid as a source of stem cells

被引:1
|
作者
Walentowicz, Pawel [1 ,2 ]
Sadlecki, Pawel [1 ,2 ]
Walentowicz-Sadlecka, Malgorzata [1 ,3 ]
Bajek, Anna [4 ]
Grabiec, Marek [1 ]
Drewa, Tomasz [5 ]
机构
[1] Nicolaus Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, PL-85168 Bydgoszcz, Poland
[2] Reg Polyclin Hosp, Dept Obstet Gynecol & Oncol Gynecol, PL-87100 Torun, Poland
[3] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, PL-01809 Warsaw, Poland
[4] Nicolaus Copernicus Univ, Dept Tissue Engn, PL-85092 Bydgoszcz, Poland
[5] Nicolaus Copernicus Univ Torun, Ludw Rydygier Med Coll Bydgoszcz, Dept Regenerat Med Cell & Tissue Bank, Chair Urol, PL-85094 Bydgoszcz, Poland
来源
OPEN MEDICINE | 2022年 / 17卷 / 01期
关键词
CORD BLOOD; PREDICTORS; QUALITY; FETAL;
D O I
10.1515/med-2022-0468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human amniotic fluid collected during amniocentesis contains a heterogeneous population of differentiated and undifferentiated cells. Properties and number of these cells vary depending on the gestational age and the presence of potential fetal pathologies. The aim of this study was to analyze the effects of maternal, fetal, and environmental factors on the success rates of amniotic fluid stem cell cultures, the number of human amniotic fluid stem cells (hAFSC), their growth rates in primary cultures, and the number of cell passages. The study included 355 patients qualified for genetic amniocentesis at the Prenatal Genetic Unit, Department of Obstetrics, Gynecology and Oncologic Gynecology, Nicolaus Copernicus University Medical College in Bydgoszcz in 2011-2017. The mean age of the study participants was 34 +/- 6.2 years, and mean gravidity amounted to 2.48 +/- 1.4. Amniotic fluid sample volume turned out to be a highly significant (p < 0.01) predictor of culture success, and the relationship was particularly evident in women older than 40 years. Another highly significant predictor of culture success was the presence of two cell populations in the sample (p < 0.01). The likelihood of culture success correlated significantly (p < 0.05) with the season of the year at the time of amniocentesis. The number of cell passages differed significantly depending on the maternal age (p < 0.01). The number of passages also showed a highly significant relationship with the season of the year the sample was obtained (p < 0.01). Younger maternal age was identified as a determinant of high passage number (>3), and another highly significant determinant of high passage number was the presence of two cell populations in the amniotic fluid sample (p < 0.01). Percentage of successfully established hAFSC cultures and the number of passages depended on amniotic fluid volume, the presence of two cell populations within the sample, and the season of the year. Individual characteristics of the donors, such as age and gravidity, did not exert a significant effect on the number of isolated hAFSCs and the rate of their growth. Patients' place of residence, fetal karyotype, transportation time, and purity of the samples did not affect the success rates for primary cultures and the number of passages.
引用
收藏
页码:648 / 660
页数:13
相关论文
共 50 条
  • [41] Human amniotic membrane as an alternative source of stem cells for regenerative medicine
    Diaz-Prado, Silvia
    Muinos-Lopez, Emma
    Hermida-Gomez, Tamara
    Cicione, Claudia
    Esther Rendal-Vazquez, M.
    Fuentes-Boquete, Isaac
    de Toro, Francisco J.
    Blanco, Francisco J.
    DIFFERENTIATION, 2011, 81 (03) : 162 - 171
  • [42] Mechanical properties of human amniotic fluid stem cells using nanoindentation
    Aryaei, Ashkan
    Jayasuriya, Ambalangodage C.
    JOURNAL OF BIOMECHANICS, 2013, 46 (09) : 1524 - 1530
  • [43] Mesenchymal stem cells derived from human amniotic fluid.
    Desborough, MJ
    Ruban, LN
    Moore, HD
    Anumba, DO
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 186A - 186A
  • [44] Expression of mTOR pathway proteins in human amniotic fluid stem cells
    Siegel, Nicol
    Valli, Alessandro
    Fuchs, Christiane
    Rosner, Margit
    Hengstschlaeger, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (06) : 779 - 784
  • [45] Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
    Trohatou, Ourania
    Anagnou, Nicholas P.
    Roubelakis, Maria G.
    CURRENT STEM CELL RESEARCH & THERAPY, 2013, 8 (02) : 125 - 132
  • [47] Renal tubular regeneration from human amniotic fluid stem cells
    De Filippo, R
    Perin, L
    Giuliani, S
    Maeshima, A
    Jin, D
    Sedrakyan, S
    Atala, A
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) : S47 - S47
  • [48] Amniotic Fluid and Amniotic Membrane Stem Cells: Marker Discovery
    Roubelakis, Maria G.
    Trohatou, Ourania
    Anagnou, Nicholas P.
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [49] Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic β-cells
    L. Trovato
    R. De Fazio
    M. Annunziata
    S. Sdei
    E. Favaro
    R. Ponti
    L. Marozio
    E. Ghigo
    C. Benedetto
    R. Granata
    Journal of Endocrinological Investigation, 2009, 32 : 873 - 876
  • [50] Amniotic Fluid-Derived Stem Cells as a Cell Source for Bone Tissue Engineering
    Rodrigues, Marcia T.
    Lee, Sang Jin
    Games, Manuela E.
    Reis, Rui L.
    Atala, Anthony
    Yoo, James J.
    TISSUE ENGINEERING PART A, 2012, 18 (23-24) : 2518 - 2527